Indianapolis was highlighted in a new national study because its hospitals have been particularly aggressive at expanding their geographic reach—raising concerns among health insurers and even hospitals themselves that new medical facilities and market power can only lead to higher prices.
Eli Lilly and Co., facing generic competition to two of its top drugs, needs to rely on new medicines rather than cost-cutting to overcome the revenue loss, CEO John Lechleiter said Thursday in Boston at the annual meeting of the Pharmaceutical Research and Manufacturers of America.
There is a mix of sadness, grief and anger in Beech Grove, as Franciscan Alliance moves the last of its inpatient and emergency operations from its nearly 100-year-old Beech Grove hospital to the new Franciscan St. Francis facility at Stop 11 Road and Emerson Avenue.
Bloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company with about 20 employees, Cook Group announced Monday.
Eli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
The Indianapolis-based hospital system is working with Evansville-based St. Mary's Health System to mesh some of their corporate operations.
The agent, called Amyvid, is not expected to produce high-dollar sales for Lilly, but it could help to identify patients with Alzheimer’s—and those without it—earlier, perhaps improving treatment and focusing research efforts.
Warsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal would greatly expand its sports, extremities and trauma business.
Healthcare Trust of America now handles property management and leasing for 29 buildings formerly managed by Hokanson Cos.
Indianapolis-based benefits brokerage FirstPerson acquired the small-employer human resource division of Indianapolis-based consulting firm FlashPoint last week in a bid to provide a wider array of services to small businesses.
Wall Street's favorable reaction came not only because harsh questioning by the U.S. Supreme Court’s conservative justices put in doubt the health reform law’s mandate that all Americans buy health insurance, but also because the justices raised the possibility that they would strike down requirements that insurers accept all customers, regardless of health.
Express Scripts Inc.’s $29.1 billion bid for rival drug benefit manager Medco Health Solutions Inc. won unconditional approval from U.S. antitrust regulators, clearing the way to create the biggest manager of prescription-drug benefits for corporate and government clients.
Like many Senate Republicans who have spent a few decades in Washington, U.S. Sen. Richard Lugar was for the individual health care mandate before he was against it. Two decades later, the policy is a near heretical stance among the party’s conservative base, and it threatens to derail Lugar’s reelection bid.
Businessman Donald Hamilton faces one count of health care fraud, five counts of false statements in a health care matter and two counts of money laundering. He faces a maximum sentence of 55 years if convicted on all counts.
Indianapolis-based Strand Diagnostics LLC will receive up to $30 million in investment capital over the next three years from Los Angeles-based NantWorks LLC, a seed-stage investment firm, the companies announced this week.
Roche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next two years, the company said Thursday morning.
Community Health Network will break ground this month on a $6.9 million, 4,600-square-foot expansion of its Indiana Heart Hospital, adding two operating rooms.
Leaping costs, aging populace and cash-strapped consumers will drive reform in health care industries even if court strikes down law.
The Indiana Supreme Court said Thursday that the state Family and Social Services Administration can't deny Medicaid, food stamps or welfare to people without first doing a better job of telling them why.
The nation's big insurers are spending millions to carry out President Barack Obama's health care overhaul even though there's a chance the wide-reaching law won't survive Supreme Court scrutiny.
